Functional and molecular characterization of kinin B1 and B2 receptors in human bladder cancer: implication of the PI3Kγ pathway

Kinin receptors as targets for cancer therapy

(2012) Carlos D Figueroa et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR

(2010) Hyun-Wook Rho et al.   BMC CANCER

Bladder Cancer in 2010: How Far have We Come?

(2010) B. L. Jacobs et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells - analysis of the molecular mechanisms of its antiproliferative action

(2010) Stephanie Jutras et al.   FEBS Journal

Bladder cancer: translating molecular genetic insights into clinical practice

(2010) Liang Cheng et al.   HUMAN PATHOLOGY

Targeting PI3K in neuroblastoma

(2010) Volker Spitzenberg et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway

(2009) Luis Molina et al.   BREAST CANCER RESEARCH AND TREATMENT

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

(2009) Margaret A. Knowles et al.   CANCER AND METASTASIS REVIEWS

SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia

(2009) Dah-Yuu Lu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells

(2009) Tsugunobu Andoh et al.   PEPTIDES

Differential ectonucleotidase expression in human bladder cancer cell lines

(2009) Joséli Stella et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958

(2007) Lajos Gera et al.   INTERNATIONAL IMMUNOPHARMACOLOGY